WELCOME - SUMMIT UK 2022

We are delighted to be planning the 10th anniversary edition of The E-Cigarette Summit, London, which will take place on the 18th November 2022.  In this milestone year the Summit will provide a unique opportunity to explore how the discussions and evidence on tobacco harm reduction and e-cigarettes has evolved over this decade and examine which questions have been answered, still remain and are emerging.

The role of e-cigarettes and nicotine in society raises both philosophical and scientific questions for regulators and policy makers, but the common goal of ending the smoking epidemic creates a pressing demand to ensure that these discussions are underpinned by scientific evidence and accurate communication.

The E-Cigarette Summit has a single aim of facilitating respectful dialogue and thoughtful analysis of the science from leading independent global experts, and provide a neutral platform to explore how the evidence should be interpreted to deliver the most effective health strategies to end smoking related death and disease. We look forward to celebrating our 10th anniversary with you in November.


We Are Hybrid

The London Summit will be a hybrid event and we aim to maximise the experience for everyone whether you are joining us in person, watching the live stream or catching up later on-demand.  All Summit participants will  have access to the event app where they can view the Speaker slides and follow the active chat/discussion.

We will “live stream” the Summit as per the Agenda (UK GMT)  Individual videos of speaker presentations and the panel discussions will be added to the virtual platform within 24 hours of the live event for you to watch/re-watch later.  The app will be live for 3 months after the event.

SUMMIT CHAIR 2022

Prof Ann McNeill

Professor of Tobacco Addiction,

Kings College London

Prof Ann McNeill, Professor of Tobacco Addiction & Vice Dean, Kings College London

SUMMIT SPEAKERS 2021 (2022 COMING SOON)

Paul Lincoln OBE

Chair - Tobacco: preventing uptake, promoting quitting and treating tobacco dependence

(NICE) National Institute of Clinical and Health Excellence -

Deborah Arnott

Chief Executive

Action on Smoking and Health

Hazel Cheeseman

Deputy Chief Executive & Policy Director

ASH (Action on Smoking & Health)

Dr Colin Mendelsohn MB BS (Hons)

General practitioner, Founding Chairman

Australian Tobacco Harm Reduction Association

Louise Ross

Interim Chair and Mental Health Lead for the New Nicotine Alliance

Business Development Manager - Smoke Free - Quit Smoking Now

Prof Daniel Kotz

Professor in addiction research and clinical epidemiology, Institute of General Practice

Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Germany

Prof Linda Bauld, OBE

Bruce and John Usher Chair in Public Health in the Usher Institute

College of Medicine, University of Edinburgh

Clive Bates

Director

Counterfactual Consulting Ltd

Prof Lion Shahab

Professor of Health Psychology

Department of Behavioural Science and Health, University College London

Dr Michael Pesko

Health Economist & Associate Professor

Department of Economics, Andrew Young School of Policy Studies, Georgia State University

Tim Phillips

Managing Director

ECigIntelligence/TobaccoIntelligence

Andrea Crossfield MBE

Independent Public Health Consultant and Population Health Policy Specialist

Greater Manchester Health and Social Care Partnership

Prof Alan Boobis, OBE

Emeritus Professor of Toxicology & Chair - UK Committee on Toxicity

Imperial College London

Marcus Saxton

Chairman

Independent British Vape Trade Association (IBVTA)

Prof Ann McNeill

Professor of Tobacco Addiction

Institute of Psychiatry, Psychology & Neuroscience,, Kings College London

Prof David Levy

Professor of Oncology

Lombardl Comprehensive Cancer Center, Georgetown University

Kate Pike

Co-ordinator - Trading Standards North West

Member of the Department of Health and Social Care National Tobacco Focus Group

Craig Copland

E-Cigarette Unit Manager - Vigilance and Risk Management of Medicines

MHRA - The Medicines and Healthcare products Regulatory Agency

Dr Debbie Robson RMN, PhD

Senior Lecturer in Tobacco Harm Reduction

National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London

Marc Gunther

Reporter/Journalist

Nonprofit Chronicles/Freelance

Dr Karl E. Lund

Senior Researcher

Norwegian Institute of Public Health

Rosanna O’Connor

Director, Addictions & Inclusion

Office for Health Improvement & Disparities, Department of Health and Social Care

Martin Dockrell

Tobacco Control Programme Lead

Office of Health Improvement & Disparities (OHID)

Professor Marcus Munafò

Professor of Biological Psychology and MRC Investigator

School of Psychological Science, University of Bristol

Prof Thomas J. Glynn, PhD

Adjunct Lecturer

Stanford Prevention Research Center, Stanford University School of Medicine

Prof Wayne Hall

Professor Emeritus, National Centre for Youth Substance Use Research

The University of Queensland

Professor Robert West

Professor Emeritus of Health Psychology

University College London

Prof Martin Jarvis

Emeritus Professor of Health Psychology, Department of Behavioural Science & Health

University College London

Prof Robert Beaglehole

Emeritus Professor

University of Auckland, New Zealand & Chair ASH - Action for Smokefree 2025, NZ

Prof Caitlin Notley

Chair of Addiction Sciences

University of East Anglia

Prof Robin Mermelstein

Distinguished Professor of Psychology & Director, Institute for Health Research and Policy

University of Illinois, Chicago

Cliff Douglas JD

Director, Tobacco Research Network, Adjunct Professor, Dep't of Health Management and Policy

University of Michigan School of Public Health

Dr Jamie Hartmann-Boyce

Managing Editor, Cochrane Tobacco Addiction Group & Senior Research Fellow

University of Oxford

Dr Konstantinos Farsalinos M.D

External Research Associate

University of Patras, Department of Public and Community Health, University of West Attica, Greece

Prof Peter Hajek

Professor of Clinical Psychology

Wolfson Institute of Public Health, Queen Mary University of London

KEY THEMES TO BE EXPLORED

The E-Cigarette Summit provides an evidence based environment that encourages open and respectful dialogue on the key science and current public health topics. The format includes high level briefings from global experts followed by panel discussions and audience Q&A.

  • The UK’s approach to vaping has been notably different from other countries – is the UK a trailblazer or outlier?
  • Is youth use a passing fad or a phenomenon that’s here to stay – and what does the Swedish experience tell us?
  • How should we define “Tobacco Harm Reduction” and why does language matter?
  • What are the new NICE recommendations on e-cigarettes and what are the evidence base and rationale that underpin them?
  • What can countries’ experiences with illicit tobacco, marijuana and EVALI teach us about the interplay between regulation and black markets?
  • How do we define scientific integrity in the current polarised environment
  • Do we need to be clearer about what constitutes a “conflict of interest”
  • Can combustible tobacco age-of-sale laws accelerate progress to a Smokefree 2030?
  • Are countries and NGOs putting more effort in to regulating/prohibiting non-combustible nicotine products than in addressing combustible products?
  • What are the public health lessons of the struggle against Covid-19 and how are these relevant to the struggle to achieve Smokefree 2030?

WHO SHOULD ATTEND

  • Regulators and policy/government advisors
  • Scientific/academic research community
  • Clinical Commissioning Groups/PCT’s
  • Smoking cessation practitioners/services
  • Health charities and health campaigners
  • Public health and tobacco control professionals
  • Medical/clinical health practitioners
  • Industry and other stakeholders

The Summit independently provides hosted places for vapers and individuals without funding to attend.  Please email info@smooth-events.com

WHO SHOULD ATTEND

  • Regulators and policy/government advisors
  • Scientific/research community
  • Smoking cessation practitioners/services
  • Health charities and health campaigners
  • Public health professionals and academics
  • Medical and health practitioners
  • Industry and other stakeholders

The Summit independently provides hosted places for vapers and individuals without funding to attend.  These places are discretionary and are considered on a case by case basis.  If you would like to find out more please contact us by email on info@smooth-events.com